We believe in the bacterial revolution 3/02/2026  |  Probiotherapy  |  6 min read "Within eighteen months, our YUN products will reach two billion people worldwide," says our founder & CEO Tom Verlinden. With six unique, globally recognized patent families, the ...

Why measuring microbial impact matters: inside YUN's Microbiome Safe Scoring System 22/12/2025  |  Probiotherapy  |  10 min read "Mild is not the same as microbiome-safe. Our scoring system shows the difference. Microbiome safety is measurable and the bacteria tell us ...

Animalcare and YUN announce strategic partnership to lead probiotherapeutical innovation in veterinary medicine 12/12/2025  |  Probiotherapy  |  7 min read Animalcare Group plc, a leading European veterinary pharmaceutical company, and YUN, a Belgian biotech innovator in human probiotherapy, announced a ...

Biotics & the Skin Microbiome: How Probiotics, Prebiotics & Postbiotics are shaping the future of Dermatology 05/12/2025  |  Probiotherapy  |  10 min read "Biotics are no longer a trend — they are the scientific foundation for a new generation of ...

Bausch Health Partners with YUN to bring pioneering microbiome skincare to Poland 04/12/2025  |  Probiotherapy  |  7 min read Left: Tom Verlinden, CEO & founder of YUN - Right: Cees Heiman, Senior Vice President, Europe & Canada Bausch Health This ...